COMMITMENTS AND CONTINGENCIES (Details Narrative)					12 Months Ended
	Aug. 04, 2016 USD ($)	May 19, 2016 USD ($)	Feb. 29, 2016 USD ($) Patient	Jun. 10, 2013	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Rent expense					$ 325,960	$ 234,322
Litigation settlement, amount	$ 1,800,000
2017					$ 23,470
Columbia University Agreement [Member]
Non-refundable start up fees			$ 23,000
Patient enrollment fees			$ 15,000
Number of patients | Patient			30
Other pass through costs			$ 30,000
Additional fee per patient			$ 4,600
Anticipated screen failure rate			25.00%
KriSan Biotech Co. Ltd [Member] | Research and Development Arrangement [Member]
Long term purchase commitment amount		$ 136,000
A5 Genetics KFT [Member] | Irrevocable License And Service Agreement [Member]
Termination date				Feb. 23, 2016